{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:52:22Z","timestamp":1792173142015,"version":"4.4.0"},"reference-count":19,"publisher":"American Veterinary Medical Association (AVMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["javma"],"published-print":{"date-parts":[[2026,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To determine the effects of medetomidine-vatinoxan (Zenalpha; MVZ) on echocardiographic parameters, blood pressure, and cardiac rhythm in healthy dogs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Healthy, client-owned dogs were eligible for enrollment in this prospective, pretest\/posttest study. Exclusion criteria included preexisting cardiac disease or medications that could alter the measured study parameters. Echocardiography, blood pressure, and 1-hour Holter monitor were performed at baseline and after sedation with MVZ per the manufacturer\u2019s guidelines. Multiple echocardiographic parameters, blood pressure, and arrhythmic burden score were assessed with pairwise comparisons between baseline and sedation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>21 dogs were enrolled in the study. Compared to baseline, MVZ resulted in significant reduction in multiple echocardiography-derived systolic function parameters (including ejection fraction, fractional shortening, end-systolic volume index, stroke volume index, and fractional area change), blood pressure, and heart rate, along with prolongation in PR and absolute QT intervals; there were nonsignificant increases in corrected QT interval and arrhythmic burden scores. Thirteen of 21 dogs (62%) developed or had worsening of atrioventricular nodal conduction on Holter monitor, while 2 of 21 (9.5%) developed or had worsening atrial or ventricular ectopic activity. Of all measured echocardiographic systolic function parameters, 15 of 21 dogs (71.4%) had 2 or more parameters below reference range with MVZ sedation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Sedation with MVZ resulted in significant changes to multiple cardiovascular and hemodynamic parameters.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical Relevance<\/jats:title>\n                    <jats:p>The cardiovascular effects of MVZ should be considered prior to sedation in dogs with, or being screened for, cardiovascular disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2460\/javma.26.03.0210","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T16:23:55Z","timestamp":1786724635000},"page":"1-6","source":"Crossref","is-referenced-by-count":0,"title":["Medetomidine-vatinoxan (Zenalpha) results in reduction of systolic function, blood pressure, and heart rate with prolongation of electrocardiographic intervals in healthy dogs"],"prefix":"10.2460","volume":"264","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-2441-9694","authenticated-orcid":true,"given":"Kiersten K.","family":"Forsyth","sequence":"first","affiliation":[{"name":"Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Purdue University, West Lafayette, IN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel F.","family":"Hogan","sequence":"additional","affiliation":[{"name":"Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Purdue University, West Lafayette, IN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis F. N.","family":"Dos Santos","sequence":"additional","affiliation":[{"name":"Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Purdue University, West Lafayette, IN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin-Yi","family":"Weng","sequence":"additional","affiliation":[{"name":"Department of Comparative Pathobiology, College of Veterinary Medicine, Purdue University, West Lafayette, IN"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1272","reference":[{"issue":"1","key":"ref1","series-title":"Vet Radiol Ultrasound","first-page":"8","article-title":"Effects of intravenous dexmedetomidine on cardiac characteristics measured using radiography and echocardiography in six healthy dogs","volume":"57","author":"Wang HC","year":"2016","unstructured":"Wang HC, Hung CT, Lee WM, Chang KM, Chen KS. Effects of intravenous dexmedetomidine on cardiac characteristics measured using radiography and echocardiography in six healthy dogs. Vet Radiol Ultrasound. 2016;57(1):8-15. doi:10.1111\/vru.12305"},{"issue":"4","key":"ref2","series-title":"J Vet Cardiol","first-page":"282","article-title":"Sedative and echocardiographic effects of dexmedetomidine combined with butorphanol in healthy dogs","volume":"17","author":"Kellihan HB","year":"2015","unstructured":"Kellihan HB, Stepien RL, Hassen KM, Smith LJ. Sedative and echocardiographic effects of dexmedetomidine combined with butorphanol in healthy dogs. J Vet Cardiol. 2015;17(4):282-292. doi:10.1016\/j.jvc.2015.08.008"},{"issue":"3","key":"ref3","series-title":"Vet Anaesth Analg","first-page":"185","article-title":"Effects of isoflurane on echocardiographic parameters in healthy dogs","volume":"35","author":"Sousa MG","year":"2008","unstructured":"Sousa MG, Carareto R, De-Nardi AB, Brito FLC, Nunes N, Camacho AA. Effects of isoflurane on echocardiographic parameters in healthy dogs. Vet Anaesth Analg. 2008;35(3):185-190. doi:10.1111\/j.1467-2995.2007.00370.x"},{"issue":"5","key":"ref4","series-title":"Am J Vet Res","first-page":"587","article-title":"Cardiopulmonary and sedative effects of the peripheral \u03b12-adrenoceptor antagonist MK 0467 administered intravenously or intramuscularly concurrently with medetomidine in dogs","volume":"73","author":"Rolfe NG","year":"2012","unstructured":"Rolfe NG, Kerr CL, McDonell WN. Cardiopulmonary and sedative effects of the peripheral \u03b12-adrenoceptor antagonist MK 0467 administered intravenously or intramuscularly concurrently with medetomidine in dogs. Am J Vet Res. 2012;73(5):587-594. doi:10.2460\/ajvr.73.5.587"},{"issue":"1","key":"ref5","series-title":"Vet Anaesth Analg","first-page":"e118","article-title":"Efficacy of a medetomidine-vatinoxan combination drug (Zenalpha) in dogs - a clinical field trial","volume":"50","author":"Turunen H","year":"2023","unstructured":"Turunen H, Zimmerman N. Efficacy of a medetomidine-vatinoxan combination drug (Zenalpha) in dogs - a clinical field trial. Vet Anaesth Analg. 2023;50(1):e118-e119. doi:10.1016\/j.vaa.2022.09.030"},{"issue":"5","key":"ref6","series-title":"Vet Anaesth Analg","first-page":"397","article-title":"Evaluation of cardiovascular effects of intramuscular medetomidine and a medetomidine-vatinoxan combination in Beagle dogs: a randomized blinded crossover laboratory study","volume":"50","author":"Joerger FB","year":"2023","unstructured":"Joerger FB, Wieser ML, Steblaj B, Niemann L, Turunen H, Kutter APN. Evaluation of cardiovascular effects of intramuscular medetomidine and a medetomidine-vatinoxan combination in Beagle dogs: a randomized blinded crossover laboratory study. Vet Anaesth Analg. 2023;50(5):397-407. doi:10.1016\/j.vaa.2023.05.004"},{"issue":"3","key":"ref7","series-title":"Vet Anaesth Analg","first-page":"417","article-title":"Plasma concentration and cardiovascular effects of intramuscular medetomidine combined with three doses of the peripheral alpha2-antagonist MK-467 in dogs","volume":"44","author":"Restitutti F","year":"2017","unstructured":"Restitutti F, Kaartinen J, Raekallio MR, Wejberg O, Mikkola E, del Castillo JRE,  Plasma concentration and cardiovascular effects of intramuscular medetomidine combined with three doses of the peripheral alpha2-antagonist MK-467 in dogs. Vet Anaesth Analg. 2017;44(3):417-426. doi:10.1016\/j.vaa.2016.04.006"},{"issue":"6","key":"ref8","series-title":"Vet Anaesth Analg","first-page":"567","article-title":"The cardiopulmonary effects of a peripheral alpha-2-adrenoceptor antagonist, MK-467, in dogs sedated with a combination of medetomidine and butorphanol","volume":"41","author":"Salla K","year":"2014","unstructured":"Salla K, Restitutti F, Vainionp\u00e4\u00e4 M, Junnila J, Honkavaara J, Kuusela E,  The cardiopulmonary effects of a peripheral alpha-2-adrenoceptor antagonist, MK-467, in dogs sedated with a combination of medetomidine and butorphanol. Vet Anaesth Analg. 2014;41(6):567-574. doi:10.1111\/vaa.12158"},{"issue":"4","key":"ref9","series-title":"J Vet Intern Med","first-page":"247","article-title":"Recommendations for standards in transthoracic two-dimensional echocardiography in the dog and cat","volume":"7","author":"Thomas WP","year":"1993","unstructured":"Thomas WP, Gaber CE, Jacobs GJ, Kaplan PM, Lombard CW, Moise NS,  Recommendations for standards in transthoracic two-dimensional echocardiography in the dog and cat. J Vet Intern Med. 1993;7(4):247-252. doi:10.1111\/j.1939-1676.1993.tb01015.x"},{"key":"ref10","series-title":"J Vet Cardiol","first-page":"15","article-title":"Echocardiographic assessment of dilated cardiomyopathy in dogs","volume":"40","author":"Bonagura JD","year":"2022","unstructured":"Bonagura JD, Visser LC. Echocardiographic assessment of dilated cardiomyopathy in dogs. J Vet Cardiol. 2022;40:15-50. doi:10.1016\/j.jvc.2021.08.004"},{"key":"ref11","article-title":"Package insert","author":"Zenalpha","year":"2021","unstructured":"Zenalpha. Package insert. Dechra Veterinary Products; 2021."},{"issue":"4","key":"ref12","series-title":"J Vet Intern Med","first-page":"1800","article-title":"Cardiac diagnostic test results and outcomes in 44 dogs naturally infected with Trypanosoma cruzi","volume":"35","author":"Matthews DJ","year":"2021","unstructured":"Matthews DJ, Saunders AB, Meyers AC, Gordon SG, Hamer SA. Cardiac diagnostic test results and outcomes in 44 dogs naturally infected with Trypanosoma cruzi. J Vet Intern Med. 2021;35(4):1800-1809. doi:10.1111\/jvim.16166"},{"issue":"2","key":"ref13","series-title":"J Vet Intern Med","first-page":"724","article-title":"Echocardiographic reference intervals for volumetric measurements of the left ventricle using the Simpson\u2019s method of discs in 1331 dogs","volume":"35","author":"Wess G","year":"2021","unstructured":"Wess G, Bauer A, Kopp A. Echocardiographic reference intervals for volumetric measurements of the left ventricle using the Simpson\u2019s method of discs in 1331 dogs. J Vet Intern Med. 2021;35(2):724-738. doi:10.1111\/jvim.16089"},{"issue":"5","key":"ref14","series-title":"J Vet Intern Med","first-page":"1909","article-title":"Echocardiographic quantitation of left heart size and function in 122 healthy dogs: a prospective study proposing reference intervals and assessing repeatability","volume":"33","author":"Visser LC","year":"2019","unstructured":"Visser LC, Ciccozzi MM, Sintov DJ, Sharpe AN. Echocardiographic quantitation of left heart size and function in 122 healthy dogs: a prospective study proposing reference intervals and assessing repeatability. J Vet Intern Med. 2019;33(5):1909-1920. doi:10.1111\/jvim.15562"},{"key":"ref15","series-title":"Clinical Echocardiography of the Dog and Cat","first-page":"111","article-title":"Global left ventricular systolic function assessment","author":"de Madron \u00c9","year":"2015","unstructured":"de Madron \u00c9. Global left ventricular systolic function assessment. In: de Madron \u00c9, Chetboul V, Bussadori C, eds. Clinical Echocardiography of the Dog and Cat. Elsevier; 2015:111\u2013125."},{"key":"ref16","series-title":"Small Animal Diagnostic Ultrasound","first-page":"217","article-title":"Echocardiography","author":"Bonagura JD","year":"2015","unstructured":"Bonagura JD, Fuentes VL. Echocardiography. In: Mattoon JS, Nyland TG, eds. Small Animal Diagnostic Ultrasound. 3rd ed. Saunders; 2015:217\u2013331."},{"key":"ref17","series-title":"J Vet Cardiol","first-page":"7","article-title":"The impact of intravenous medetomidine and vatinoxan on echocardiographic evaluation of dogs with stage B1 mitral valve disease","volume":"54","author":"V\u00e4lim\u00e4ki E","year":"2024","unstructured":"V\u00e4lim\u00e4ki E, Lepp\u00e4nen H, Turunen H, Raekallio M, Honkavaara J. The impact of intravenous medetomidine and vatinoxan on echocardiographic evaluation of dogs with stage B1 mitral valve disease. J Vet Cardiol. 2024;54:7-17. doi:10.1016\/j.jvc.2024.04.003"},{"issue":"6","key":"ref18","series-title":"Vet Surg","first-page":"612","article-title":"Hemodynamic effects of medetomidine in the dog: a dose titration study","volume":"27","author":"Pypendop BH","year":"1998","unstructured":"Pypendop BH, Verstegen JP. Hemodynamic effects of medetomidine in the dog: a dose titration study. Vet Surg. 1998;27(6):612-622. doi:10.1111\/j.1532-950x.1998.tb00539.x"},{"issue":"2","key":"ref19","series-title":"Res Vet Sci","first-page":"687","article-title":"Echocardiographic evaluation of the cardiovascular effects of medetomidine, acepromazine and their combination in healthy dogs","volume":"95","author":"Saponaro V","year":"2013","unstructured":"Saponaro V, Crovace A, De Marzo L, Centonze P, Staffieri F. Echocardiographic evaluation of the cardiovascular effects of medetomidine, acepromazine and their combination in healthy dogs. Res Vet Sci. 2013;95(2):687-692. doi:10.1016\/j.rvsc.2013.03.022"}],"container-title":["Journal of the American Veterinary Medical Association"],"original-title":[],"link":[{"URL":"https:\/\/avmajournals.avma.org\/view\/journals\/javma\/264\/11\/javma.26.03.0210.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/avmajournals.avma.org\/downloadpdf\/journals\/javma\/264\/11\/javma.26.03.0210.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/avmajournals.avma.org\/downloadpdf\/journals\/javma\/264\/11\/javma.26.03.0210.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:25:12Z","timestamp":1792171512000},"score":1,"resource":{"primary":{"URL":"https:\/\/avmajournals.avma.org\/view\/journals\/javma\/264\/11\/javma.26.03.0210.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11,1]]},"references-count":19,"journal-issue":{"issue":"11"},"URL":"https:\/\/doi.org\/10.2460\/javma.26.03.0210","relation":{},"ISSN":["0003-1488"],"issn-type":[{"value":"0003-1488","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11,1]]}}}